
Dairy Study: Somatic Cell Reduction
MASTITIS STUDY KEY POINTS:
- Somatic Cell Count Reduction: 59.7%
- OMRI Listed Product
A study on somatic cell counts was conducted involving 26 cows with chronically high somatic cell counts. Thirteen cows were randomly assigned to the study group, while the other thirteen formed the control group. Initial testing on August 21, 2003, revealed that the control group had an average somatic cell count of 1,854,811, while the treatment group had an average count of 2,374,000.
During the 60-day study period, the control group received standard mastitis treatment protocols. In contrast, the cows in the study group were given one ounce of Ramaekers Livestock Stress Stable daily for three days, followed by three days off, for a total of three cycles (nine treatments).
Somatic cell count testing was repeated on September 18, 2003. The control group experienced a 10.5% increase in somatic cell counts, whereas the study group saw a significant decrease of 59.7%. This results in a 70.2% improvement in somatic cell counts when compared to the control group.
Of the treated cows, nine returned to production, while only one cow from the control group recovered after receiving heavy medication.
Summary: Mastitis Study

Using an OMRI-listed immune support product can be more effective than drug therapy for mastitis. Ideally, immune support products like LSSS should be used as preventative measures. Additionally, there are no withdrawal times associated with LSSS.